Transcend Capital Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$496K Buy
4,193
+1,333
+47% +$154K 0.03% 457
2026
Q1
$342K Buy
2,860
+283
+11% +$37.1K 0.03% 502
2025
Q4
$351K Buy
2,577
+122
+5% +$17.5K 0.03% 475
2025
Q3
$362K Buy
2,455
+102
+4% +$14.1K 0.03% 468
2025
Q2
$304K Buy
2,353
+41
+2% +$4.96K 0.02% 456
2025
Q1
$276K Sell
2,312
-119
-5% -$14.7K 0.02% 495
2024
Q4
$282K Buy
2,431
+19
+0.8% +$2.4K 0.02% 454
2024
Q3
$326K Buy
2,412
+77
+3% +$10.3K 0.02% 463
2024
Q2
$317K Buy
+2,335
New +$318K 0.02% 448

Other funds holding XYL

Transcend Capital Advisors's XYL Position: Q2 2026 in Review

Transcend Capital Advisors increased its Xylem (XYL) stake by 47% in Q2 2026, buying an estimated $154K and bringing the position to 4,193 shares worth $496K. The position accounts for 0.03% of the portfolio, ranked #457.

Transcend Capital Advisors first reported a position in XYL in Q2 2024 and has held it in 9 quarters since. 1,103 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Transcend Capital Advisors held 4,193 shares of Xylem worth $496K as of Q2 2026.
  • Transcend Capital Advisors bought 1,333 Xylem shares in Q2 2026, an estimated $154K.
  • Xylem made up 0.03% of Transcend Capital Advisors's portfolio in Q2 2026, its #457 holding.
  • Transcend Capital Advisors first reported a position in Xylem in Q2 2024 and has held it in 9 quarters since.
  • 1,103 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.